Pharmacokinetics of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Hepatic Disease
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate whether liver patients may tolerate alitretinoin by comparing
metabolism in 8 such patients with the metabolism in 8 healthy controls